Last reviewed · How we verify

Co-administration of MMR/YF

Alba Maria Ropero · FDA-approved active Biologic

Co-administration of MMR/YF is a vaccine Biologic drug developed by Alba Maria Ropero. It is currently FDA-approved for Prevention of measles, mumps, and rubella in individuals requiring yellow fever vaccination, Simultaneous immunization against MMR and yellow fever in travelers or at-risk populations.

Co-administration of MMR and yellow fever vaccines provides simultaneous immunization against measles, mumps, rubella, and yellow fever through live attenuated viral antigens.

Co-administration of MMR and yellow fever vaccines provides simultaneous immunization against measles, mumps, rubella, and yellow fever through live attenuated viral antigens. Used for Prevention of measles, mumps, and rubella in individuals requiring yellow fever vaccination, Simultaneous immunization against MMR and yellow fever in travelers or at-risk populations.

At a glance

Generic nameCo-administration of MMR/YF
SponsorAlba Maria Ropero
Drug classvaccine
ModalityBiologic
Therapeutic areaImmunology
PhaseFDA-approved

Mechanism of action

MMR vaccine contains live attenuated viruses that stimulate cellular and humoral immune responses against measles, mumps, and rubella. Yellow fever vaccine (YF) contains a live attenuated yellow fever virus that induces protective immunity. Co-administration allows both vaccines to be given together, potentially improving compliance and convenience while maintaining individual vaccine efficacy.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Co-administration of MMR/YF

What is Co-administration of MMR/YF?

Co-administration of MMR/YF is a vaccine drug developed by Alba Maria Ropero, indicated for Prevention of measles, mumps, and rubella in individuals requiring yellow fever vaccination, Simultaneous immunization against MMR and yellow fever in travelers or at-risk populations.

How does Co-administration of MMR/YF work?

Co-administration of MMR and yellow fever vaccines provides simultaneous immunization against measles, mumps, rubella, and yellow fever through live attenuated viral antigens.

What is Co-administration of MMR/YF used for?

Co-administration of MMR/YF is indicated for Prevention of measles, mumps, and rubella in individuals requiring yellow fever vaccination, Simultaneous immunization against MMR and yellow fever in travelers or at-risk populations.

Who makes Co-administration of MMR/YF?

Co-administration of MMR/YF is developed and marketed by Alba Maria Ropero (see full Alba Maria Ropero pipeline at /company/alba-maria-ropero).

What drug class is Co-administration of MMR/YF in?

Co-administration of MMR/YF belongs to the vaccine class. See all vaccine drugs at /class/vaccine.

What development phase is Co-administration of MMR/YF in?

Co-administration of MMR/YF is FDA-approved (marketed).

What are the side effects of Co-administration of MMR/YF?

Common side effects of Co-administration of MMR/YF include Injection site reactions (pain, erythema, swelling), Fever, Rash, Myalgia, Headache.

Related